This grant by the National Institute on Drug Abuse (NIDA), part of NIH’s HEAL Prevention Initiative, targets the national opioid crisis. Its purpose is to develop and test new or adapted interventions to prevent opioid misuse among patients in community health centers (CHCs). It also supports developing and testing implementation strategies for screening and referral to preventive interventions for opioid and other substance misuse within CHCs. Funded as exploratory/developmental phase awards (R61/R33), projects can last up to five years, allocating two years for development and four for full research aims testing.
Opportunity ID: 342742
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-DA-23-048 |
Funding Opportunity Title: | HEAL Initiative: Research Studies to Develop and Implement Interventions to Prevent Opioid Misuse in Community Health Centers (R61/R33 Clinical Trial Required) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Education Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.213 — Research and Training in Complementary and Integrative Health |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Jul 26, 2022 |
Last Updated Date: | Jul 26, 2022 |
Original Closing Date for Applications: | Nov 08, 2022 |
Current Closing Date for Applications: | Nov 08, 2022 |
Archive Date: | Dec 14, 2022 |
Estimated Total Program Funding: | – |
Award Ceiling: | $750,000 |
Award Floor: | – |
Eligibility
Eligible Applicants: | Private institutions of higher education Public housing authorities/Indian housing authorities For profit organizations other than small businesses County governments City or township governments Others (see text field entitled “Additional Information on Eligibility” for clarification) Independent school districts Native American tribal governments (Federally recognized) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education State governments Special district governments Public and State controlled institutions of higher education Small businesses Native American tribal organizations (other than Federally recognized tribal governments) |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | NIH is issuing this Funding Opportunity Announcement (FOA) in response to the declared public health emergency issued by the Secretary, HHS, for the national opioid crisis. This research is part of the Helping to End Addiction Long-term (HEAL) Prevention Initiative, a portfolio of research focused on the prevention of opioid misuse and opioid use disorder funded under NIHs HEAL Initiative. The National Institute on Drug Abuse (NIDA) seeks to address the urgency and magnitude of the opioid crisis by developing and testing new or adapted interventions to prevent opioid misuse among patients served by community health centers (CHCs), and/or developing and testing implementation strategies for screening and referral to preventive interventions for misuse of opioids and other substances among patients served by CHCs. Research will be supported through exploratory/developmental phase awards (R61/R33) that may not exceed 5 years, allocating up to two years of funding for development of the project and up to four years for a full test of the research aims. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-048.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
OERWebmaster03@od.nih.gov Email:OERWebmaster03@od.nih.gov |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
Folder 342742 Full Announcement-RFA-DA-23-048 -> RFA-DA-23-048-Full-Announcement.pdf
Packages
Agency Contact Information: | NIH OER Webmaster OERWebmaster03@od.nih.gov Email: OERWebmaster03@od.nih.gov |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-G | Use for due dates on or after January 25, 2022 | PKG00276189 | Oct 08, 2022 | Nov 08, 2022 | View |
Package 1
Mandatory forms
342742 RR_SF424_5_0-5.0.pdf
342742 PHS398_CoverPageSupplement_5_0-5.0.pdf
342742 RR_OtherProjectInfo_1_4-1.4.pdf
342742 PerformanceSite_4_0-4.0.pdf
342742 RR_KeyPersonExpanded_4_0-4.0.pdf
342742 RR_Budget_3_0-3.0.pdf
342742 PHS398_ResearchPlan_4_0-4.0.pdf
342742 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
342742 RR_SubawardBudget30_3_0-3.0.pdf
342742 PHS_AssignmentRequestForm_3_0-3.0.pdf